Cargando…

Levonorgestrel release rates measured through analysis of two-rod contraceptive explants

OBJECTIVE: The objective was to characterize and compare in vivo rates of levonorgestrel (LNG) release from Sino-implant (II) and Jadelle® contraceptive implants. STUDY DESIGN: We sampled 48 Sino-implant (II) and 49 Jadelle® explant sets for residual LNG content from participants treated for up to 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuchs, Rachael, Taylor, Douglas, Jenkins, David W., Brache, Vivian, Luo, Diane, Dorflinger, Laneta J., Steiner, Markus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509190/ https://www.ncbi.nlm.nih.gov/pubmed/32995746 http://dx.doi.org/10.1016/j.conx.2020.100039

Ejemplares similares

A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation()
por: Halpern, Vera, et al.
Publicado: (2023)

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial
por: Deese, Jennifer, et al.
Publicado: (2022)

Return to ovulation after Sayana Press is injected every 4 months for one year: Empirical and pharmacokinetic/pharmacodynamic modeling results()
por: Taylor, Douglas J., et al.
Publicado: (2022)

Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic()
por: Steiner, M.J., et al.
Publicado: (2019)

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016)

Contraception in the Era of COVID-19
por: Nanda, Kavita, et al.
Publicado: (2020)

Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial
por: Halpern, Vera, et al.
Publicado: (2021)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022)

Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
por: Halpern, Vera, et al.
Publicado: (2021)

Planning for Outcomes (P(4)O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix
por: Lebetkin, Elena, et al.
Publicado: (2019)

Models and methods to characterise levonorgestrel release from intradermally administered contraceptives
por: Al Dalaty, Adnan, et al.
Publicado: (2021)

Menstrual Pattern and Characteristics of One-Rod and Two-Rod Levonorgestrel Implant Users
por: Gunardi, Eka Rusdianto, et al.
Publicado: (2021)

WHO Tiered-Effectiveness Counseling Is Rights-Based Family Planning
por: Stanback, John, et al.
Publicado: (2015)

Potential biomarkers to predict return to fertility after discontinuation of female contraceptives—looking to the future
por: Cordova-Gomez, Amanda, et al.
Publicado: (2023)

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling
por: Costescu, Dustin J
Publicado: (2016)

Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Impact of one-rod levonorgestrel implant on the blood chemistry profile
por: Gunardi, Eka R., et al.
Publicado: (2021)

Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review
por: Zgliczynska, Magdalena, et al.
Publicado: (2020)

Pregnancy rate after emergency contraception with single‐dose oral levonorgestrel in Japanese women
por: Sakurai, Shigeru
Publicado: (2019)

Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China
por: Che, Y, et al.
Publicado: (2019)

Association between knowledge about levonorgestrel emergency contraception and the risk of ectopic pregnancy following levonorgestrel emergency contraception failure: a comparative survey
por: Zhang, Duo, et al.
Publicado: (2016)

An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
por: Janagam, Dileep R., et al.
Publicado: (2016)

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
por: de Oliveira, Elaine Cristina Fontes, et al.
Publicado: (2023)

The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Over-The-Counter Availability of Levonorgestrel Emergency Contraception in Pharmacies on Oahu
por: Chin, Jennifer, et al.
Publicado: (2020)

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()
por: Heffron, Renee, et al.
Publicado: (2019)

A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
por: Monteiro-Dantas, Cecilia, et al.
Publicado: (2007)

More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years
por: Gemzell-Danielsson, Kristina, et al.
Publicado: (2021)

Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception
por: Eriksson, Karin, et al.
Publicado: (2020)

Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data?
por: Kardos, László
Publicado: (2020)

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz
por: Carten, Monica L., et al.
Publicado: (2012)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
por: Meece, Frederick A., et al.
Publicado: (2018)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel
por: Yavuz, Burcin, et al.
Publicado: (2020)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6nfshdme1gadu1jv413atm85hq